Evidence map›Paper›PMID 30065563›Full record

ReviewWorld journal of gastroenterology2018

Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients.

Bettina M Buchholz, Panagis M Lykoudis, Reena Ravikumar, Joerg M Pollok, Giuseppe K Fusai

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Current Treatment of Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Comprehensive Review.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2026
    Review
  5. Article
  6. Postoperative detection ofTransplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
  7. Article
  8. [Liver transplantation in viral and autoimmune liver diseases].Innere Medizin (Heidelberg, Germany) · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Essential updates 2018/2019: Liver transplantation.Annals of gastroenterological surgery · 2020
    Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Bettina M BuchholzDepartment of HPB Surgery and Liver Transplantation, Royal Free Hospital London, London NW32QG, United Kingdom.
Panagis M LykoudisDepartment of HPB Surgery and Liver Transplantation, Royal Free Hospital London, London NW32QG, United Kingdom.
Reena RavikumarDepartment of HPB Surgery and Liver Transplantation, Royal Free Hospital London, London NW32QG, United Kingdom.
Joerg M PollokDepartment of HPB Surgery and Liver Transplantation, Royal Free Hospital London, London NW32QG, United Kingdom.
Giuseppe K FusaiDepartment of HPB Surgery and Liver Transplantation, Royal Free Hospital London, London NW32QG, United Kingdom.
The Royal Free Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo study the published evidence on the impact of colectomy in preventing recurrent primary sclerosing cholangitis (rPSC).

methodsAn unrestricted systematic literature search in PubMed, EMBASE, Medline OvidSP, ISI Web of Science, Lista (EBSCO) and the Cochrane library was performed on clinical studies investigating colectomy in liver transplantation (LT) recipients with and without rPSC in the liver allograft. Study quality was evaluated according to a modification of the methodological index for non-randomized studies (MINORS) criteria. Primary endpoints were the impact of presence, timing and type of colectomy on rPSC. Overall presence of inflammatory bowel disease (IBD), time of IBD diagnosis, posttransplant IBD and immunosuppressive regimen were investigated as secondary outcome.

resultsThe literature search yielded a total of 180 publications. No randomized controlled trial was identified. Six retrospective studies met the inclusion criteria of which 5 studies were graded as high quality articles. Reporting of IBD was heterogenous but in four publications, either inflammatory bowel disease, ulcerative colitis or in particular active colitis post-LT significantly increased the risk of rPSC. The presence of an intact (

conclusionThe data favours a protective role of pre-/peri-LT colectomy in rPSC but the current evidence is not strong enough to recommend routine colectomy for rPSC prevention.

Indexed as

ColectomyCholangitis, SclerosingColonCyclosporineDysbiosisGastrointestinal MicrobiomeHumansImmunosuppressive AgentsInflammatory Bowel DiseasesLiver TransplantationPerioperative CareRisk AssessmentRisk FactorsSecondary PreventionTacrolimusTreatment OutcomeCyclosporineImmunosuppressive AgentsTacrolimusColectomyLiver transplantationRecurrent primary sclerosing cholangitisRisk factorUlcerative colitis

Identifiers

PMID30065563
PMCPMC6064960
OpenAlexW2884760786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.